Sight Sciences (SGHT)
(Real Time Quote from BATS)
$5.10 USD
-0.14 (-2.67%)
Updated Apr 19, 2024 03:53 PM ET
After-Market: $5.15 +0.05 (0.98%) 4:12 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Income Statements
Fiscal Year end for Sight Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 81 | 71 | 49 | 28 | NA |
Cost Of Goods | 12 | 12 | 9 | 9 | NA |
Gross Profit | 69 | 59 | 40 | 18 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 126 | 143 | 92 | 51 | 0 |
Income After Depreciation & Amortization | -57 | -84 | -51 | -32 | 0 |
Non-Operating Income | 7 | 2 | -7 | 0 | NA |
Interest Expense | 5 | 4 | 4 | 2 | NA |
Pretax Income | -55 | -86 | -63 | -35 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -56 | -86 | -63 | -35 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -56 | -86 | -63 | -35 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -56 | -83 | -50 | -31 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | NA |
Income After Depreciation & Amortization | -57 | -84 | -51 | -32 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 48.63 | 47.85 | 26.73 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.14 | -1.80 | -2.36 | NA | NA |
Diluted Net EPS (GAAP) | -1.14 | -1.80 | -2.36 | NA | NA |
Fiscal Year end for Sight Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 18.75 | 20.01 | 23.47 | 18.82 |
Cost Of Goods | NA | 2.77 | 2.68 | 3.38 | 3.05 |
Gross Profit | NA | 15.98 | 17.33 | 20.09 | 15.78 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 27.09 | 30.74 | 35.28 | 33.35 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -11.11 | -13.41 | -15.19 | -17.57 |
Non-Operating Income | NA | 1.78 | 1.89 | 1.79 | 1.79 |
Interest Expense | NA | 1.35 | 1.43 | 1.35 | 1.28 |
Pretax Income | NA | -10.68 | -12.96 | -14.75 | -17.05 |
Income Taxes | NA | 0.01 | 0.08 | 0.01 | 0.01 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -10.69 | -13.04 | -14.75 | -17.07 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -10.69 | -13.04 | -14.75 | -17.07 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 48.90 | 48.67 | 48.54 | 48.41 |
Diluted EPS Before Non-Recurring Items | NA | -0.22 | -0.27 | -0.30 | -0.35 |
Diluted Net EPS (GAAP) | NA | -0.22 | -0.27 | -0.30 | -0.35 |